• Using AI-driven modelling tools to predict optimal delivery parameters tailored to antigen type, immune profile, and patient-specific variables
• Imbedding computational formulation insights with biomaterial engineering to enhance mRNA stability, targeting, and immune activation
• Accelerating design–build–test cycles by minimizing formulation guesswork and enabling data-informed delivery system optimization

NOVEL MRNA MODALITY

NEW COMPANY